World's Best Scientists 2026 revealed!
Chiara Riganti

Chiara Riganti

D-Index & Metrics

Biology and Biochemistry

D-Index
66
Citations
15560
World Ranking
8672
National Ranking
236

Overview

Chiara Riganti is affiliated with the University of Turin in Italy and has a significant research portfolio primarily in the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Their work spans molecular biology, oncology, pulmonary and respiratory medicine, and cancer research, with strong intersections in materials chemistry.

The scientist's main areas of study include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Subfields of particular focus are:

  • Molecular Biology
  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research
  • Materials Chemistry

Chiara Riganti's research topics encompass drug transport and resistance mechanisms, cancer biology, hypoxia, metabolism, nanoparticle-based drug delivery, lung diseases related to occupation and environment, cancer therapeutics, crystallization and solubility studies, and X-ray diffraction in crystallography.

  • Drug Transport and Resistance Mechanisms
  • Cancer, Hypoxia, and Metabolism
  • Nanoparticle-Based Drug Delivery
  • Occupational and environmental lung diseases
  • Cancer therapeutics and mechanisms
  • Crystallization and Solubility Studies
  • X-ray Diffraction in Crystallography

Among the recent publications associated with Chiara Riganti are:

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death, 2020, Journal for ImmunoTherapy of Cancer
  • Hypoxia as a driver of resistance to immunotherapy, 2021, Drug Resistance Updates
  • Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons, 2021, Journal of Experimental & Clinical Cancer Research
  • Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells, 2020, Biomolecules
  • Impact of cancer metabolism on therapy resistance - Clinical implications, 2021, Drug Resistance Updates

Frequent co-authors include:

  • Joanna Kopecka
  • Iris C. Salaroglio
  • Martina Godel
  • Dimas Carolina Belisario
  • Marialessandra Contino

Chiara Riganti has published frequently in several venues such as:

  • The Cambridge Structural Database
  • Journal of Experimental & Clinical Cancer Research
  • International Journal of Molecular Sciences
  • Journal of Medicinal Chemistry
  • Cancers

Best Publications

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Lorenzo Galluzzi;Ilio Vitale;Sarah Warren;Sandy Adjemian

  • Consensus guidelines for the detection of immunogenic cell death

    Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli

  • The pentose phosphate pathway: an antioxidant defense and a crossroad in tumor cell fate.

    Chiara Riganti;Elena Gazzano;Manuela Polimeni;Elisabetta Aldieri

  • Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

    Abhishek D. Garg;Lorenzo Galluzzi;Lionel Apetoh;Lionel Apetoh;Thais Baert

  • Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux.

    Chiara Riganti;Erica Miraglia;Daniele Viarisio;Costanzo Costamagna

  • Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway

    Marta Coscia;Elena Quaglino;Manuela Iezzi;Claudia Curcio

  • Diphenyleneiodonium Inhibits the Cell Redox Metabolism and Induces Oxidative Stress

    Chiara Riganti;Elena Gazzano;Manuela Polimeni;Costanzo Costamagna

  • Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific

    Elisabetta Aldieri;Chiara Riganti;Manuela Polimeni;Elena Gazzano

  • Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-kB activation

    Elisabetta Aldieri;Daniela Atragene;Loredana Bergandi;Chiara Riganti

  • HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast

    Sophie Michelle Doublier;Dimas Carolina Belisario;Manuela Polimeni;Laura Annaratone

  • Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets.

    Joanna Kopecka;Patrick Trouillas;Ana Čipak Gašparović;Elena Gazzano

  • PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy

    Iris Chiara Salaroglio;Elisa Panada;Elisa Panada;Enrico Moiso;Ilaria Buondonno

  • Hypoxia as a driver of resistance to immunotherapy

    Joanna Kopecka;Iris C. Salaroglio;Elizabeth Perez-Ruiz;Ana Bela Sarmento-Ribeiro

  • Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1α and P-glycoprotein overexpression.

    Chiara Riganti;Sophie Michelle Doublier;D Viarisio;Erica Miraglia

  • ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer

    Iris C. Salaroglio;Eleonora Mungo;Elena Gazzano;Joanna Kopecka

  • Fluoride effects: the two faces of janus.

    E. Gazzano;L. Bergandi;C. Riganti;E. Aldieri

  • Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest

    Michela Capello;Sammy Ferri-Borgogno;Sammy Ferri-Borgogno;Chiara Riganti;Michelle Samuel Chattaragada

  • Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells.

    Chiara Riganti;Claudia Voena;Joanna Kopecka;Paola Antonia Corsetto

  • Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis

    Moitza Principe;Simone Borgoni;Mariafrancesca Cascione;Michelle Samuel Chattaragada

  • Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition

    Giada Gelsomino;Paola A Corsetto;Ivana Campia;Gigliola Montorfano

Frequent Co-Authors

Dario Ghigo
Dario Ghigo University of Turin
Amalia Bosia
Amalia Bosia University of Turin
Massimo Massaia
Massimo Massaia University of Turin
Mario Boccadoro
Mario Boccadoro University of Turin
Francesco Novelli
Francesco Novelli University of Turin
Michele Lanotte
Michele Lanotte University of Turin
Salvatore Sortino
Salvatore Sortino University of Catania
Silvia Novello
Silvia Novello University of Turin
Bice Fubini
Bice Fubini University of Turin
Silvia Deaglio
Silvia Deaglio University of Turin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens doors to a wide range of healthcare and science careers. Many students complement their studies by pursuing flexible online degrees and certificates tailored to specialized roles in healthcare and nutrition.

For those interested in mental health, the shortest online pmhnp certificate programs provide an accelerated pathway to become a Psychiatric Mental Health Nurse Practitioner. Alternatively, nurses seeking advancement might consider a 1 year post master's fnp online program, which enables quick completion for a Family Nurse Practitioner certification.

Nutrition-focused graduates can pursue a dietitian degree online to gain credentials in dietetics while maintaining flexibility. Registered Nurses may also benefit from rn to bsn online no clinicals options, making it easier to advance their education with fewer on-site requirements.

Whether your interests are in laboratory science, patient care, or nutrition, these online pathways support flexible learning and diverse career outcomes after a foundation in Biology or Biochemistry.

Best Scientists Citing Chiara Riganti

Trending Scientists

Recently Published Articles